The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective

F. Borgström; Å. Carlsson; H. Sintonen; S. Boonen; P. Haentjens; R. Burge; O. Johnell; B. Jönsson; J. A. Kanis

doi:10.1007/s00198-006-0094-1

The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective

Osteoporosis International ◽

10.1007/s00198-006-0094-1 ◽

2006 ◽

Vol 17 (7) ◽

pp. 996-1007 ◽

Cited By ~ 41

Author(s):

F. Borgström ◽

Å. Carlsson ◽

H. Sintonen ◽

S. Boonen ◽

P. Haentjens ◽

...

Keyword(s):

Cost Effectiveness ◽

International Perspective ◽

Treatment Of Osteoporosis ◽

The Cost

Download Full-text

The Cost Effectiveness of Bisphosphonates for the Prevention and Treatment of Osteoporosis

PharmacoEconomics ◽

10.2165/00019053-200725110-00003 ◽

2007 ◽

Vol 25 (11) ◽

pp. 913-933 ◽

Cited By ~ 42

Author(s):

Rachael L Fleurence ◽

Cynthia P Iglesias ◽

Jeanene M Johnson

Keyword(s):

Cost Effectiveness ◽

Treatment Of Osteoporosis ◽

Prevention And Treatment ◽

The Cost

Download Full-text

The burden of osteoporosis in Brazil

Arquivos Brasileiros de Endocrinologia & Metabologia ◽

10.1590/0004-2730000003203 ◽

2014 ◽

Vol 58 (5) ◽

pp. 434-443 ◽

Cited By ~ 19

Author(s):

Bruna Coelho Galvão Marinho ◽

Luiza Paulino Guerra ◽

Juliana Beaudette Drummond ◽

Barbara C. Silva ◽

Maria Marta Sarquis Soares

Keyword(s):

Cost Effectiveness ◽

Financial Burden ◽

Scientific Evidence ◽

Treatment Strategies ◽

Indirect Costs ◽

Osteoporotic Fractures ◽

Fragility Fractures ◽

Treatment Of Osteoporosis ◽

The Cost ◽

The Impact

Osteoporotic fractures impose severe physical, psychosocial, and financial burden both to the patient and the society. Studies on the prevalence of osteoporosis and fragility fractures in Brazil show a wide variation, due to differences in sample size, the population studied, and methodologies. Few studies have been conducted in Brazil about the cost-effectiveness analyses of different intervention options aimed at the diagnosis and treatment of osteoporosis. Investigation and treatment strategies based on cost-effectiveness and scientific evidence are essential in the preparation of public health policies with the ultimate goal of reducing the incidence of fractures and, consequently, the direct and indirect costs associated with them. This article reviews the Brazilian burden of osteoporosis in terms of the prevalence and fractures attributable to the disease, the costs related to the investigation and management, as well as the impact of osteoporosis on the population as a whole and on affected individuals.

Download Full-text

Measuring and valuing health: an international perspective

10.1093/med/9780198725923.003.0011 ◽

2016 ◽

Author(s):

John Brazier ◽

Julie Ratcliffe ◽

Joshua A. Salomon ◽

Aki Tsuchiya

Keyword(s):

Developing Countries ◽

Cost Effectiveness ◽

International Perspective ◽

General Observation ◽

Middle Income ◽

Middle Income Countries ◽

Disability Adjusted Life ◽

Key Issues ◽

The Cost ◽

Disability Adjusted Life Year

The institutionalized demand for cost-effectiveness evidence in low- and middle-income countries—where this sort of information is arguably even more urgently required—has yet to gain traction to the same extent that it has in various countries in the industrialized world. There are several important exceptions to this general observation, and these may signal a rising interest in undertaking and applying cost-effectiveness analysis (CEAs) in developing countries. The disability-adjusted life year (DALY) is an alternative to the QALY that has been favoured in much of the cost-effectiveness work in developing countries; and extends the discussions of key issues in the definition, description, and valuation of health to address some of the added considerations demanded by cross-cultural applications of the methods and tools that are the focus of this book.

Download Full-text